Skip to main content

FDA recall, , Moderate risk

ORL Kids Mouthwash and Natural Toothpaste

Signature Formulations is recalling its ORL Kids Mouthwash and ORL Kids Natural Toothpaste because of cGMP deviations.

What happened

Signature Formulations, LLC of Phoenix, Arizona, recalled ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), and ORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz. (500ml) per bottle, both distributed by ORL Labs, LLC, Scottsdale, Arizona USA. The FDA stated the reason as cGMP Deviations. The company began the recall on December 8, 2025, and the FDA added it to the Enforcement Report and classified it on January 5, 2026. Distribution was AZ only.

2 photos

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is your bottle affected?

2 products

Affected if its lot code is listed.

  1. ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USA

    Lot code
    • 250520P4
  2. ORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz. (500ml) per bottle, ORL Labs, LLC, Scottsdale, Arizona USA

    Lot code
    • 250505P9

Recall details

Company began the recall
Company
Signature Formulations, LLCPhoenix, Arizona
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98131
Recall numbers
D-0252-2026 to D-0253-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)